The competition between these three enzymes was tested by selective suppression of C1GALT1, resulting in increased expressions of sialyl-Tn and GSL-II binding (Core-3 glycans) in human colon cancer cells [35]. Here, C1GALT1 is linked to colonic neoplasm.